Navigation Links
Cornerstone Therapeutics to Present at the 6th Annual Lazard Capital Markets Healthcare Conference
Date:11/16/2009

CARY, N.C., Nov. 16 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (Nasdaq CM: CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that David Price, Executive Vice President and Chief Financial Officer, will be presenting a corporate overview at the 6th Annual Lazard Capital Markets Healthcare Conference at 9:00AM EST on Wednesday, November 18, 2009 at The St. Regis Hotel in New York City.

About Cornerstone Therapeutics

Cornerstone Therapeutics Inc. (Nasdaq CM: CRTX), headquartered in Cary, N.C., is a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets. The Company currently promotes multiple marketed products in the United States to respiratory-focused physicians and key retail pharmacies with its specialty sales force. The Company also has a late-stage clinical pipeline with a recent regulatory submission filing and four additional regulatory approval submissions targeted within the next three years. Key elements of the Company's strategy are to in-license or acquire rights to underpromoted, patent-protected, branded respiratory or related pharmaceutical products or late-stage product candidates; implement life cycle management strategies to maximize the potential value and competitive position of the Company's currently marketed products, newly acquired products and product candidates that are currently in development; grow product revenue through the Company's specialty sales force, which is focused on the respiratory and related markets; and maintain and strengthen the intellectual property position of the Company's currently marketed products, newly acquired products and product candidates.

Safe Harbor Statement

This press release includes for
'/>"/>

SOURCE Cornerstone Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance
2. Cornerstone Therapeutics to Host Quarter and Year Ended December 31, 2008 Conference Call
3. Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results
4. Cornerstone Therapeutics to Present at BioCenturys 2009 Future Leaders in the Biotech Industry Conference
5. Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect to Charter Amendments
6. Cornerstone Therapeutics Announces Closing of Chiesi Transaction
7. Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive(R)
8. Cornerstone Therapeutics to Host Third Quarter 2009 Conference Call
9. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
10. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
11. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... July 29, 2014  United Therapeutics Corporation (NASDAQ: ... financial results for the second quarter ended ... shows that our medicines are reaching increasing ... hypertension (PAH)," said Martine Rothblatt, Ph.D., United ... commercial launch this quarter of our extended-release ...
(Date:7/29/2014)... Boston, MA (PRWEB) July 29, 2014 ... the Library of Congress was recently awarded to Juliana ... in Stoneham, MA, for their project, “From an Egg, ... from among 3,000 final entries for the National History ... more than 300 historians and educators in Washington, D.C. ...
(Date:7/29/2014)... CAMBRIDGE, England , July 29, 2014 ... das Liquid Biopsy System (LBS) zur Erfassung ... an den Herzkranzgefäßen entwickelt und patentiert. Das ... Stellen innerhalb der Koronararterie des Patienten und ... Das LBS hat das Potenzial, die Entdeckung ...
(Date:7/28/2014)... Texas (PRWEB) July 28, 2014 ... and China Lubricant Industry” is a professional ... Global Lubricant market. The report introduces Lubricant ... and industry chain structure and industry overview. ... including China’s domestic market as well as ...
Breaking Biology Technology:United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 2United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 3United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 4United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 5United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 6United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 7United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 8United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 9United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 10United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 11United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 12United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 13In Vitro Fertilization (IVF) was the Subject of This Year’s Winning Entry for the Prestigious Library of Congress “Discovery or Exploration in History Award” 2In Vitro Fertilization (IVF) was the Subject of This Year’s Winning Entry for the Prestigious Library of Congress “Discovery or Exploration in History Award” 3PlaqueTec sichert sich CE-Kennzeichnung für Liquid Biopsy System - bahnbrechende Innovation zur Erfassung neuer biologischer Informationen aus erkranktem Herzkranzgefäß 2PlaqueTec sichert sich CE-Kennzeichnung für Liquid Biopsy System - bahnbrechende Innovation zur Erfassung neuer biologischer Informationen aus erkranktem Herzkranzgefäß 3PlaqueTec sichert sich CE-Kennzeichnung für Liquid Biopsy System - bahnbrechende Innovation zur Erfassung neuer biologischer Informationen aus erkranktem Herzkranzgefäß 4Lubricant Market & Adhesion Promoter Industry (Globa, China) Analysis Now Available at DeepResearchReports.com 2Lubricant Market & Adhesion Promoter Industry (Globa, China) Analysis Now Available at DeepResearchReports.com 3Lubricant Market & Adhesion Promoter Industry (Globa, China) Analysis Now Available at DeepResearchReports.com 4
... SANTA ANA, Calif. , July 21 Irvine Scientific announced ... in women,s health, located in Neuilly en Thelle, France. Effective ... embryo transfer catheters, oocyte retrieval needles, and intra-uterine insemination cannulas ... Prodimed has a long history of developing superior products ...
... Mich., July 21 Neogen Corporation (Nasdaq: NEOG ) ... year, which ended May 31, and a continuation of the company,s ... Neogen,s revenues for FY 2009 were $118,721,000, up from $102,418,000 ... in currency exchange rates that had an unfavorable impact of $2.7 ...
... JERUSALEM, Israel, July 21 Oramed,Pharmaceuticals, ... alternative drug delivery systems, today reported positive results from ... on type 1 diabetic,patients. The completion of this study ... Diabetes Mellitus, whereas, all Oramed,s trials up to,date have ...
Cached Biology Technology:Neogen Reports 16% Increase in Revenues 2Neogen Reports 16% Increase in Revenues 3Neogen Reports 16% Increase in Revenues 4Neogen Reports 16% Increase in Revenues 5Neogen Reports 16% Increase in Revenues 6Oramed Pharmaceuticals Reports Positive Results From a Study of Oral Insulin Capsule on Type 1 Diabetic Patients 2
(Date:7/28/2014)... body,s natural virus killers to prevent and treat HIV ... strong inflammatory response these molecules can arouse as they ... by scientists at the Weizmann Institute and the National ... activity of these molecules interferons around the ... course of the disease. Their research appeared in ...
(Date:7/28/2014)... Biologically Inspired Engineering at Harvard University today announced ... by a newly formed private company to accelerate ... products. The announcement follows a worldwide ... (OTD) and the start-up Emulate Inc., relating to ... platform. , "This is a big win ...
(Date:7/28/2014)... the first man to reach the South Pole in ... international team of scientists led by Joe McConnell of ... pollution from industrial activities arrived long before. , Using ... locations around the Antarctic continent, including the South Pole, ... to date of lead pollution over the Earth,s southernmost ...
Breaking Biology News(10 mins):Interfering with interferon 2Wyss Institute's technology translation engine launches 'Organs-on-Chips' company 2Wyss Institute's technology translation engine launches 'Organs-on-Chips' company 3Industrial lead pollution beat explorers to the South Pole by 22 years and persists today 2Industrial lead pollution beat explorers to the South Pole by 22 years and persists today 3
... Changes in how genes in the immune system function ... cause of visual impairment in older adults, based on ... investigators. "Our findings are epigenetic in nature, ... expression has been modified, likely by environmental factors, in ...
... , A peer-reviewed study of the largest number of flame ... levels of at least one flame retardant that exceeded a ... will publish the study online on November 28, 12:01am ... Institute tested for 49 flame retardant chemicals in household dust, ...
... Tension is the theme running through the new ... international working group on stem cell research and ... and scientific norms of free exchange, but also ... interests, and privatized vs. nationalized health care systems. ...
Cached Biology News:NIH study suggests immune system could play a central role in AMD 2NIH study suggests immune system could play a central role in AMD 3New study: Many flame retardants in house dust -- unsafe levels 2New study: Many flame retardants in house dust -- unsafe levels 3East Asia faces unique challenges, opportunities for stem cell innovation 2East Asia faces unique challenges, opportunities for stem cell innovation 3
... unit ideal for use in laboratories with low ... set at 12 rpm , Temperature control ... capacity of four 35 x 150mm bottles, eight ... , Consistent, repeatable results achieved with microprocessor ...
... particle based purification systems provide high speed ... sample. They offer increased throughput and reproducible ... KingFisher, KingFisher mL and KingFisher 96, covering ... Each system consists of an instrument, specially ...
... DNA120OP is specifically engineered for efficient drying ... incorporates a glass cover and a post-trap ... unattended, odor-free processing of samples in ammonium ... Synthetic Oligos , ...
... is a no-frills, basic SpeedVac concentrator designed ... priced, this unit still features a standard ... display of time and heat. It is ... accepts a wide variety of different rotors ...
Biology Products: